BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16615877)

  • 1. Management of marginal zone lymphomas.
    Thieblemont C; Coiffier B
    Curr Treat Options Oncol; 2006 May; 7(3):213-22. PubMed ID: 16615877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical presentation and management of marginal zone lymphomas.
    Thieblemont C
    Hematology Am Soc Hematol Educ Program; 2005; ():307-13. PubMed ID: 16304396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project.
    Nathwani BN; Anderson JR; Armitage JO; Cavalli F; Diebold J; Drachenberg MR; Harris NL; MacLennan KA; Müller-Hermelink HK; Ullrich FA; Weisenburger DD
    J Clin Oncol; 1999 Aug; 17(8):2486-92. PubMed ID: 10561313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma).
    Nathwani BN; Drachenberg MR; Hernandez AM; Levine AM; Sheibani K
    Semin Hematol; 1999 Apr; 36(2):128-38. PubMed ID: 10319381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary nodal marginal zone lymphomas of splenic and MALT type.
    Campo E; Miquel R; Krenacs L; Sorbara L; Raffeld M; Jaffe ES
    Am J Surg Pathol; 1999 Jan; 23(1):59-68. PubMed ID: 9888704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marginal zone-related neoplasms of splenic and nodal origin.
    Arcaini L; Paulli M; Boveri E; Magrini U; Lazzarino M
    Haematologica; 2003 Jan; 88(1):80-93. PubMed ID: 12551831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients.
    Berger F; Felman P; Thieblemont C; Pradier T; Baseggio L; Bryon PA; Salles G; Callet-Bauchu E; Coiffier B
    Blood; 2000 Mar; 95(6):1950-6. PubMed ID: 10706860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Marginal Zone Lymphoma: A Canadian Perspective.
    Peters A; Keating MM; Nikonova A; Doucette S; Prica A
    Curr Oncol; 2023 Feb; 30(2):1745-1759. PubMed ID: 36826096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukaemic subtype of marginal zone lymphoma: a presentation of three cases and literature review.
    Tam CS; Prince HM; Westerman D; Seymour JF; Juneja S
    Leuk Lymphoma; 2004 Apr; 45(4):705-10. PubMed ID: 15160943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare lymphomas in routine practice - Treatment and outcome in marginal zone lymphoma in the prospective German Tumour Registry Lymphatic Neoplasms.
    Knauf W; Abenhardt W; Koenigsmann M; Maintz C; Sandner R; Zahn MO; Schnell R; Tech S; Kaiser-Osterhues A; Houet L; Marschner N;
    Hematol Oncol; 2021 Aug; 39(3):313-325. PubMed ID: 33942348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marginal zone lymphomas.
    Zucca E; Rossi D; Bertoni F
    Hematol Oncol; 2023 Jun; 41 Suppl 1():88-91. PubMed ID: 37294969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database.
    Olszewski AJ; Castillo JJ
    Cancer; 2013 Feb; 119(3):629-38. PubMed ID: 22893605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marginal zone lymphoma: old, new, targeted, and epigenetic therapies.
    Joshi M; Sheikh H; Abbi K; Long S; Sharma K; Tulchinsky M; Epner E
    Ther Adv Hematol; 2012 Oct; 3(5):275-90. PubMed ID: 23616915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marginal zone B-cell lymphomas.
    Sagaert X; Tousseyn T
    Discov Med; 2010 Jul; 10(50):79-86. PubMed ID: 20670602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Marginal zone lymphomas: extranodal MALT type, nodal and splenic].
    Dallenbach FE; Coupland SE; Stein H
    Pathologe; 2000 Mar; 21(2):162-77. PubMed ID: 10840821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marginal zone lymphoma.
    Shaye OS; Levine AM
    J Natl Compr Canc Netw; 2006 Mar; 4(3):311-8. PubMed ID: 16507274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marginal zone B-cell lymphoma: lessons from Western and Eastern diagnostic approaches.
    Nakamura S; Ponzoni M
    Pathology; 2020 Jan; 52(1):15-29. PubMed ID: 31757436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marginal zone lymphomas: management of nodal, splenic, and MALT NHL.
    Kahl B; Yang D
    Hematology Am Soc Hematol Educ Program; 2008; ():359-64. PubMed ID: 19074110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Front-line management of indolent non-Hodgkin lymphoma in Australia. Part 2: mantle cell lymphoma and marginal zone lymphoma.
    Cheah CY; Opat S; Trotman J; Marlton P
    Intern Med J; 2019 Sep; 49(9):1070-1080. PubMed ID: 30816618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma.
    Hoffmann M; Kletter K; Becherer A; Jäger U; Chott A; Raderer M
    Oncology; 2003; 64(4):336-40. PubMed ID: 12759529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.